| scholarly article | Q13442814 |
| P2093 | author name string | T Jake Liang | |
| Barbara Rehermann | |||
| Theo Heller | |||
| Koji Hara | |||
| Jay H Hoofnagle | |||
| Christopher Koh | |||
| Maria M Rivera | |||
| Sandra Page | |||
| Mary Demino | |||
| Pothu Raju Nagabhyru | |||
| P2860 | cites work | Hepatitis C virus infection | Q27861002 |
| Diagnosis, management, and treatment of hepatitis C: an update | Q29619682 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
| The liver biopsy in chronic hepatitis C: a view from the other side of the microscope | Q30778829 | ||
| Occult hepatitis C: how convincing are the current data? | Q33395436 | ||
| Introduction to therapy of hepatitis C. | Q34984075 | ||
| Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. | Q35596873 | ||
| Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses | Q36103046 | ||
| Long-term outcome of chronic hepatitis C after sustained virological response to interferon-based therapy | Q36769099 | ||
| Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. | Q42989655 | ||
| 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. | Q42990190 | ||
| Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir | Q42994495 | ||
| How sustained is sustained viral response in patients with hepatitis C virus infection? | Q42999496 | ||
| Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin | Q43899942 | ||
| Long-term follow-up of patients with chronic hepatitis C with sustained virologic response to interferon | Q50558431 | ||
| Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients | Q50561200 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | virology | Q7215 |
| hepatitis C | Q154869 | ||
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 38-45 | |
| P577 | publication date | 2013-10-14 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection? | |
| P478 | volume | 209 |
| Q34802167 | Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin |
| Q38860634 | Current views on interferon therapy for HIV. |
| Q40199411 | Hepatitis C Virus Relapse 78 Weeks After Completion of Successful Direct-Acting Therapy |
| Q35501190 | Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade |
| Q42162220 | Incidence and antiviral response of hepatitis C virus reactivation in lupus patients undergoing immunosuppressive therapy |
| Q59351616 | Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection |
| Q37476369 | MISSEL: a method to identify a large number of small species-specific genomic subsequences and its application to viruses classification. |
| Q38270747 | New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis |
| Q41940972 | Next-generation sequencing sheds light on the natural history of hepatitis C infection in patients who fail treatment |
| Q36237433 | Peripheral Blood Mononuclear Cell Gene Expression Remains Broadly Altered Years after Successful Interferon-Based Hepatitis C Virus Treatment |
| Q28076352 | Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis |
| Q36158391 | Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir |
| Q34781537 | Will there be a vaccine to prevent HCV infection? |
Search more.